STAT3 potentiates RNA polymerase I-directed transcription and tumor growth by activating RPA34 expression

Zhang, Cheng, Wang, Juan, Song, Xiaoye, Yu, Deen, Guo, Baoqiang ORCID: https://orcid.org/0000-0002-5469-4621, Pang, Yaoyu, Yin, Xiaomei, Zhao, Shasha, Deng, Huan, Zhang, Shihua and Deng, Wensheng (2023) STAT3 potentiates RNA polymerase I-directed transcription and tumor growth by activating RPA34 expression. British Journal of Cancer, 128 (5). pp. 766-782. ISSN 0007-0920

Preview	Accepted Version Available under License In Copyright. Download (3MB) | Preview
Preview	Supplemental Material Available under License In Copyright. Download (2MB) | Preview

Abstract

Background: Deregulation of either RNA polymerase I (Pol I)-directed transcription or expression of signal transducer and activator of transcription 3 (STAT3) correlates closely with tumorigenesis. However, the connection between STAT3 and Pol I-directed transcription hasn’t been investigated. Methods: The role of STAT3 in Pol I-directed transcription was determined using combined techniques. The regulation of tumor cell growth mediated by STAT3 and Pol I products was analyzed in vitro and in vivo. RNAseq, ChIP assays and rescue assays were used to uncover the mechanism of Pol I transcription mediated by STAT3. Results: STAT3 expression positively correlates with Pol I product levels and cancer cell growth. The inhibition of STAT3 or Pol I products suppresses cell growth. Mechanistically, STAT3 activates Pol I-directed transcription by enhancing the recruitment of the Pol I transcription machinery to the rDNA promoter. STAT3 directly activates Rpa34 gene transcription by binding to the RPA34 promoter, which enhances the occupancies of the Pol II transcription machinery factors at this promoter. Cancer patients with RPA34 high expression lead to poor survival probability and short survival time. Conclusion: STAT3 potentiates Pol I-dependent transcription and tumor cell growth by activating RPA34 in vitro and in vivo.